November 20, 2023
2 min watch
Save
VIDEO: Atia Vision CEO delivers update on OmniVu IOL system
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Mariam Maghribi of Atia Vision and Shifamed, delivers updates from each company including developments for the OmniVu IOL system.
“We have demonstrated the full range of functional vision for patients with minimal visual disturbances and are building up to get into the U.S. [investigational device exemption] study hopefully next year,” she said.
Maghribi also previewed an upcoming titratable therapy for the treatment of moderate to severe glaucoma.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Maghribi reports being president and CEO of Atia Vision and chief business officer for Shifamed.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.